📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Chir99021 and Valproic acid reduce the proliferative advantage of Apc mutant cells. (2018)

First Author: Langlands AJ

Attributed to: Sonopill: minimally invasive gastrointestinal diagnosis and therapy funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41419-017-0199-9

PubMed Identifier: 29449562

Publication URI: http://europepmc.org/abstract/MED/29449562

Type: Journal Article/Review

Volume: 9

Parent Publication: Cell death & disease

Issue: 3